Zynrelef
Total Payments
$7.9M
Transactions
13,225
Doctors
7,718
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $6.1M | 7,607 | 4,719 |
| 2021 | $1.9M | 5,618 | 3,796 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $5.4M | 397 | 68.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.1M | 498 | 13.9% |
| Consulting Fee | $721,040 | 482 | 9.1% |
| Food and Beverage | $403,194 | 10,969 | 5.1% |
| Travel and Lodging | $273,340 | 877 | 3.4% |
| Space rental or facility fees (teaching hospital only) | $14,000 | 1 | 0.2% |
| Grant | $10,000 | 1 | 0.1% |
Payments by Type
Research
$5.4M
397 transactions
General
$2.5M
12,828 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE | Heron Therapeutics, Inc. | $2.6M | 0 |
| HTX-011 in Spinal Surgery | Heron Therapeutics, Inc. | $1.7M | 0 |
| Herniorrhaphy Study for Opioid Elimination | Heron Therapeutics, Inc. | $523,615 | 0 |
| Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimen | Heron Therapeutics, Inc. | $361,371 | 0 |
| HTX-011 Administration Study in Planned Caesarean Section Procedure | Heron Therapeutics, Inc. | $236,880 | 0 |
| Pediatric Postoperative Analgesia Herniorrhaphy Study | Heron Therapeutics, Inc. | $20,000 | 0 |
| Retrospective Chart Review of patients that have undergone lap colectomy | Heron Therapeutics, Inc. | $500.00 | 0 |
Top Doctors Receiving Payments for Zynrelef
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Cleveland, OH | $5.4M | 401 |
| , MD | Orthopaedic Surgery | Houston, TX | $277,073 | 269 |
| , M.D | Anesthesiology | Plano, TX | $156,642 | 225 |
| , MD | Surgery | Durham, NC | $147,448 | 218 |
| , MD | Adult Reconstructive Orthopaedic Surgery | Fremont, CA | $133,623 | 126 |
| , M.D, | Specialist | Bend, OR | $95,066 | 144 |
| Mark Marino | Internal Medicine | Carlsbad, CA | $94,950 | 8 |
| , M.D | Specialist | La Mesa, CA | $90,388 | 38 |
| , MD | Surgical Critical Care | Shreveport, LA | $74,004 | 104 |
| , M.D | Anesthesiology | Philadelphia, PA | $66,751 | 57 |
| Paul Lachiewicz | — | Chapel Hill, NC | $61,098 | 71 |
| , MD | Adult Reconstructive Orthopaedic Surgery | Poughkeepsie, NY | $48,210 | 61 |
| , DPM | Podiatrist | Slc, UT | $46,466 | 81 |
| , M.D | Anesthesiology | Cleveland, OH | $33,152 | 36 |
| , MD | Orthopaedic Surgery | Bossier City, LA | $32,103 | 50 |
| , M.D | Emergency Medicine | San Diego, CA | $31,634 | 53 |
| , M.D | Anesthesiology | Shreveport, LA | $31,066 | 44 |
| , DO | Orthopaedic Trauma | Farmington, NM | $30,825 | 36 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Palm Beach Gardens, FL | $24,770 | 48 |
| , M.D | Anesthesiology | Ann Arbor, MI | $24,476 | 20 |
| , MD | Surgery | Celebration, FL | $24,078 | 22 |
| , DPM | Foot & Ankle Surgery | Salt Lake City, UT | $23,702 | 27 |
| , PA | Physician Assistant | Houston, TX | $22,665 | 77 |
| , MD | Surgery | Holyoke, MA | $22,206 | 31 |
| , DPM | Foot & Ankle Surgery | Houston, TX | $22,187 | 38 |
Ad
Manufacturing Companies
- Heron Therapeutics, Inc. $7.9M
Product Information
- Type Drug
- Total Payments $7.9M
- Total Doctors 7,718
- Transactions 13,225
About Zynrelef
Zynrelef is a drug associated with $7.9M in payments to 7,718 healthcare providers, recorded across 13,225 transactions in the CMS Open Payments database. The primary manufacturer is Heron Therapeutics, Inc..
Payment data is available from 2021 to 2022. In 2022, $6.1M was paid across 7,607 transactions to 4,719 doctors.
The most common payment nature for Zynrelef is "Unspecified" ($5.4M, 68.1% of total).
Zynrelef is associated with 7 research studies, including "A Multi-surgery Assessment of ZYNRELEF (HTX-011), AMAZE" ($2.6M).